128 related articles for article (PubMed ID: 10506118)
1. Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N, N-didesmethyltamoxifen.
Brown K; Heydon RT; Jukes R; White IN; Martin EA
Carcinogenesis; 1999 Oct; 20(10):2011-6. PubMed ID: 10506118
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.
Gamboa da Costa G; Marques MM; Freeman JP; Beland FA
Chem Res Toxicol; 2003 Sep; 16(9):1090-8. PubMed ID: 12971796
[TBL] [Abstract][Full Text] [Related]
3. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.
Gamboa da Costa G; Marques MM; Fu X; Churchwell MI; Wang YP; Doerge DR; Beland FA
Cancer Lett; 2007 Nov; 257(2):191-8. PubMed ID: 17765393
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the major DNA adduct formed by alpha-hydroxy-N-desmethyltamoxifen in vitro and in vivo.
Gamboa da Costa G; Hamilton LP; Beland FA; Marques MM
Chem Res Toxicol; 2000 Mar; 13(3):200-7. PubMed ID: 10725117
[TBL] [Abstract][Full Text] [Related]
5. N-demethylation accompanies alpha-hydroxylation in the metabolic activation of tamoxifen in rat liver cells.
Phillips DH; Hewer A; Horton MN; Cole KJ; Carmichael PL; Davis W; Osborne MR
Carcinogenesis; 1999 Oct; 20(10):2003-9. PubMed ID: 10506117
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.
Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174
[TBL] [Abstract][Full Text] [Related]
7. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
[TBL] [Abstract][Full Text] [Related]
8. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
[TBL] [Abstract][Full Text] [Related]
9. Identification of tamoxifen-DNA adducts induced by alpha-acetoxy-N-desmethyltamoxifen.
Kitagawa M; Ravindernath A; Suzuki N; Rieger R; Terashima I; Umemoto A; Shibutani S
Chem Res Toxicol; 2000 Aug; 13(8):761-9. PubMed ID: 10956064
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method.
Martin EA; Heydon RT; Brown K; Brown JE; Lim CK; White IN; Smith LL
Carcinogenesis; 1998 Jun; 19(6):1061-9. PubMed ID: 9667745
[TBL] [Abstract][Full Text] [Related]
11. 32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen.
Martin EA; Rich KJ; White IN; Woods KL; Powles TJ; Smith LL
Carcinogenesis; 1995 Jul; 16(7):1651-4. PubMed ID: 7614701
[TBL] [Abstract][Full Text] [Related]
12. Co-chromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen-treated rats.
Phillips DH; Hewer A; White IN; Farmer PB
Carcinogenesis; 1994 May; 15(5):793-5. PubMed ID: 8200077
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
14. Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy.
Rajaniemi H; Rasanen I; Koivisto P; Peltonen K; Hemminki K
Carcinogenesis; 1999 Feb; 20(2):305-9. PubMed ID: 10069469
[TBL] [Abstract][Full Text] [Related]
15. Analysis of tamoxifen-induced DNA adducts by 32P-postlabelling assay using different chromatographic techniques.
Koskinen M; Rajaniemi H; Hemminki K
J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):155-60. PubMed ID: 9140769
[TBL] [Abstract][Full Text] [Related]
16. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
[TBL] [Abstract][Full Text] [Related]
17. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide.
Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K
Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct formation by tamoxifen and structurally-related compounds in rat liver.
Rajaniemi H; Mäntylä E; Hemminki K
Chem Biol Interact; 1998 May; 113(2):145-59. PubMed ID: 9717515
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective metabolic activation of alpha-hydroxy-N-desmethyltamoxifen: the R-isomer forms more DNA adducts in rat liver cells.
Osborne MR; Hewer A; Phillips DH
Chem Res Toxicol; 2004 May; 17(5):697-701. PubMed ID: 15144227
[TBL] [Abstract][Full Text] [Related]
20. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods.
Schild LJ; Phillips DH; Osborne MR; Hewer A; Beland FA; Churchwell MI; Brown K; Gaskell M; Wright E; Poirier MC
Mutagenesis; 2005 Mar; 20(2):115-24. PubMed ID: 15755801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]